In this video interview, Kyle McAllister, co-founder, CEO, Trially, shares real-world examples of AI transforming clinical ...

In this video interview, Kyle McAllister, co-founder, CEO, Trially, explains how staffing reductions caused by clinical trial budget cuts are threatening patient recruitment and retention and warns of ...

IntraBio Inc. announced today that it has completed recruitment for its Phase III Pivotal Trial "IB1001-303", Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T): A randomized, ...

Providing a Focused Analysis of Emerging Opportunities, Challenges, and Market Dynamics from 2024 to 2029"Boston, July 02, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, ...

The next frontier in clinical development is modelling feasibility and continuous scenario-planning, even amid changing ...

Patient recruitment remains a significant challenge for biopharma companies, often leading to delays and increased costs in clinical trials. Traditional recruitment methods can be time-consuming ...

Patients with rare diseases are increasingly working to find and fund their own cures. But should they have to?

Pfizer's recent trial termination makes it yet another company facing challenges with CD47 studies in oncology.

The clinical trial support services market is experiencing significant growth, driven by the increasing incidence of chronic illnesses such as cancer ...

Pfizer insists that the discontinuation of the Phase II study was due to recruitment difficulties and was not linked to ...

egnite has launched the CardioCare Research Suite, an advanced component of its flagship platform, aimed at enhancing patient identification processes for cardiovascular clinical trials. This tool is ...

Frost & Sullivan commends Novotech for setting a high standard in competitive strategy, execution, and market responsiveness.